Jelenia Góra, Poland

Urszula Kańska

This inventor holds 1 USPTO granted patent. Top assignee: Instytut Immunologii I Terapii Doswiadczalnej Pan. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Urszula Kańska. Retrieved from https://idiyas.com/inventor/urszula-kańska

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Urszula Kańska: Innovator in Drug-Carrier Conjugates

Introduction

Urszula Kańska is a prominent inventor based in Jelenia Góra, Poland. She has made significant contributions to the field of drug delivery systems, particularly through her innovative methods in producing polyanionic drug-carrier conjugates. Her work focuses on enhancing the therapeutic properties of macromolecules, which is crucial for advancing medical treatments.

Latest Patents

Urszula holds a patent for the "Method of production of polyanionic drug-carrier conjugates." This invention involves a unique method for creating a polyanionic macromolecule, which is a protein composed of polar amino acids such as lysine, arginine, aspartic acid, and glutamic acid. The method is characterized by a reaction between amine groups and the cyclic anhydride of dicarboxylic acid, resulting in a more negatively charged carrier. This modification leads to improved therapeutic properties of the macromolecules.

Career Highlights

Urszula Kańska is affiliated with the Institute of Immunology and Experimental Therapy, where she continues to push the boundaries of research in drug delivery systems. Her dedication to innovation has positioned her as a key figure in her field, contributing to advancements that could significantly impact patient care.

Collaborations

Urszula has collaborated with notable colleagues, including Dmitry Nevozhay and Mohamed Salah Omar Megahed. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic methods.

Conclusion

Urszula Kańska's work in the production of polyanionic drug-carrier conjugates exemplifies her commitment to innovation in the medical field. Her contributions are paving the way for more effective drug delivery systems, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…